Redefine Surgery closes Pre-seed round, taking total capital to $10m
The medical-technology company will develop its surgical-intelligence platform toward commercial readiness.
New financing within a $10m cumulative total
Redefine Surgery closed a pre-seed round that brings cumulative capital raised to $10 million. The amount of the new round and the identities of its backers were not disclosed.
The financing supports development of the company’s surgical-intelligence platform toward commercialisation. Its work begins with shoulder-replacement procedures and remains subject to product-development and regulatory milestones.
Use of funds
Develop the surgical intelligence platform toward commercialization